Bryson JC - Search Results

1

The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.

Gandara DR, Harvey WH, Monaghan GG, Perez EA, Stokes C, Bryson JC, Finn AL, Hesketh PJ. Gandara DR, et al. Among authors: bryson jc. Semin Oncol. 1992 Aug;19(4 Suppl 10):67-71. Semin Oncol. 1992. PMID: 1387253 Clinical Trial.

2

Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapy.

Hainsworth JD, Omura GA, Khojasteh A, Bryson JC, Finn AL. Hainsworth JD, et al. Among authors: bryson jc. Am J Clin Oncol. 1991 Aug;14(4):336-40. Am J Clin Oncol. 1991. PMID: 1830716 Clinical Trial.

3

Clinical safety of ondansetron.

Bryson JC. Bryson JC. Semin Oncol. 1992 Dec;19(6 Suppl 15):26-32. Semin Oncol. 1992. PMID: 1485179 Review.

4

The effectiveness of a single intravenous dose of ondansetron.

Brown GW, Paes D, Bryson J, Freeman AJ. Brown GW, et al. Oncology. 1992;49(4):273-8. doi: 10.1159/000227056. Oncology. 1992. PMID: 1387927 Clinical Trial.

5

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.

Crucitt MA, Hyman W, Grote T, Tester W, Madajewicz S, Yee S, Wentz A, Griffin D, Parasuraman TV, Bryson J. Crucitt MA, et al. Clin Ther. 1996 May-Jun;18(3):508-18. doi: 10.1016/s0149-2918(96)80032-4. Clin Ther. 1996. Corrected and republished in: Clin Ther. 1996 Jul-Aug;18(4):778-88. doi: 10.1016/s0149-2918(96)80226-8 PMID: 8829027 Corrected and republished. Clinical Trial.

6

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.

Crucitt MA, Hyman W, Grote T, Tester W, Madajewicz S, Yee S, Wentz A, Griffin D, Parasuraman TV, Bryson J. Crucitt MA, et al. Clin Ther. 1996 Jul-Aug;18(4):778-88. doi: 10.1016/s0149-2918(96)80226-8. Clin Ther. 1996. PMID: 8879903 Clinical Trial.

7

Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation.

Spitzer TR, Bryson JC, Cirenza E, Foelber R, Wallerstadt M, Stout C, Kunka RL, Plagge PB, Dubois A. Spitzer TR, et al. Among authors: bryson jc. J Clin Oncol. 1994 Nov;12(11):2432-8. doi: 10.1200/JCO.1994.12.11.2432. J Clin Oncol. 1994. PMID: 7964960 Clinical Trial.

8

Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers.

Pritchard JF, Bryson JC, Kernodle AE, Benedetti TL, Powell JR. Pritchard JF, et al. Among authors: bryson jc. Clin Pharmacol Ther. 1992 Jan;51(1):51-5. doi: 10.1038/clpt.1992.7. Clin Pharmacol Ther. 1992. PMID: 1531044 Clinical Trial.

9

Intravenous ondansetron for postsurgical opioid-induced nausea and vomiting. S3A-255 Study Group.

Rung GW, Claybon L, Hord A, Patel C, Kallgren M, Koppel J, Benedetti C, Creed M, Asgharian A, Bryson J. Rung GW, et al. Anesth Analg. 1997 Apr;84(4):832-8. doi: 10.1097/00000539-199704000-00025. Anesth Analg. 1997. PMID: 9085967 Clinical Trial.

10

Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study.

Genovese MC, Fleischmann R, Furst D, Janssen N, Carter J, Dasgupta B, Bryson J, Duncan B, Zhu W, Pitzalis C, Durez P, Kretsos K. Genovese MC, et al. Ann Rheum Dis. 2014 Sep;73(9):1607-15. doi: 10.1136/annrheumdis-2013-204760. Epub 2014 Mar 18. Ann Rheum Dis. 2014. PMID: 24641941 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters